Bright Minds Biosciences DRUG
NASDAQ DRUG
$66.64 -1.38 (-2.03%)
As of: Sep 4, 2026 · 1:32 PM EDT

Bright Minds Biosciences (DRUG) EPS (Basic) (2023 - 2026)

Bright Minds Biosciences' (DRUG) quarterly EPS (Basic) came in at $0.01 in Q4 2024, up 101.79% YoY from $0.0 in Q1 2024, and down 84.7% on a QoQ basis from $0.04 in Q2 2024.

Analysis

Bright Minds Biosciences (DRUG) EPS (Basic) (2023 - 2026) Analysis & Trends

Bright Minds Biosciences (DRUG) has 2 years of EPS (Basic) data on file, last reported at $0.01 in Q4 2024.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 139.27 Bn 131.42 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 85.55 Bn 77.56 Bn 3.93 Bn 12.62
3 Argenx Se 63.45 Bn 58.27 Bn 1.37 Bn 7.70
4 Moderna 57.73 Bn 52.59 Bn 52.00 Mn -1.96
5 Revolution Medicines 44.08 Bn 44.08 Bn - -3.06
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 2.12
7 Alnylam Pharmaceuticals 35.14 Bn 31.84 Bn 992.69 Mn 1.23
8 Royalty Pharma 28.44 Bn 27.60 Bn - 0.18
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn -0.06
10 Bright Minds Biosciences 458.56 Mn 236.02 Mn - -0.55
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.55
Mar 31, 2026 -1.39
Dec 31, 2025 -0.87
Sep 30, 2025 -1.43
Jun 30, 2025 0.96
Mar 31, 2025 0.54
Dec 31, 2024 0.01
Sep 30, 2024 -0.48
Jun 30, 2024 0.04
Mar 31, 2024 0.34
Dec 31, 2023 -0.33
Sep 30, 2023 -1.48
Jun 30, 2023 -0.44